206 results

• Xeljanz Side Effects May Increase Risk of Cancer, Serious Heart Problems: FDA Alert

  February 5, 2021

  Russell Maas

  A new FDA warning indicates Xeljanz side effects may increase the risk of heart problems, including heart attacks, and cancer in patients over 50.

• FDA Approves High-Dose, Extended-Release Version of Xeljanz, Despite Blood Clot Risks

  December 20, 2019

  Irvin Jackson

  The FDA has approved higher dose formulations of extended release Xeljanz, despite concerns over the risk of potentially fatal blood clots.

• Blood Clot Problems from Xeljanz Draw Updated EMA Warning for High Risk Patients

  November 5, 2019

  Irvin Jackson

  European regulators warn that Xeljanz should not be given to any patients at high risk of blood clots unless absolutely necessary.

• Pulmonary Embolism Patients Fare Better At High-Volume Hospitals: Study

  August 16, 2019

  Russell Maas

  A new study finds that patients suffering from a pulmonary embolism have a better chance of survival if they go to a busy hospital.

• Zelboraf, Cotellic, Similar Melanoma Drugs May Cause Heart Problems: Study

  August 14, 2019

  Irvin Jackson

  A new study warns that some melanoma drugs used in combination may increase the risk of serious heart problems.

• Xeljanz Black Box Warning Added by FDA, Due to Risk of Blood Clots and Death

  July 26, 2019

  Irvin Jackson

  The FDA is warning that Pfizer's ulcerative colitis drug, Xeljanz, could cause pulmonary embolism and deep vein thrombosis at higher doses.

• IVC Filter Placement Following Traumatic Injury Failed To Reduce Risk of Pulmonary Embolism, Death: Study

  July 16, 2019

  Irvin Jackson

  A new study finds that early placement of IVC filters does not reduce the risk of pulmonary embolism or death in patients who have suffered severe trauma.

• Xeljanz Side Effects at 10mg Dose Lead EMA To Place Restrictions on Use

  May 20, 2019

  Irvin Jackson

  European regulators have placed new restrictions on the use of Xeljanz while they continue to review potential pulmonary embolism risks.

• Xeljanz Pulmonary Embolism Problems 5-Fold Higher Than Other Rheumatoid Arthritis Drugs: Study

  April 16, 2019

  Irvin Jackson

  Xeljanz side effects may increase the risk of pulmonary embolism by a factor of five when taken at higher doses, according to the preliminary findings of a clinical trial.

• Lawsuit Over Xeljanz Generic Copy Filed by Pfizer

  April 3, 2019

  Irvin Jackson

  Pfizer is suing Ajanta Pharma over plans to release a generic version of Xeljanz years before its patent protection is scheduled to run out.